Judith Staerk

6.9k total citations · 1 hit paper
34 papers, 5.0k citations indexed

About

Judith Staerk is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Judith Staerk has authored 34 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Genetics and 11 papers in Oncology. Recurrent topics in Judith Staerk's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Pluripotent Stem Cells Research (9 papers) and Cytokine Signaling Pathways and Interactions (9 papers). Judith Staerk is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Pluripotent Stem Cells Research (9 papers) and Cytokine Signaling Pathways and Interactions (9 papers). Judith Staerk collaborates with scholars based in Belgium, United States and Norway. Judith Staerk's co-authors include Stefan N. Constantinescu, William Vainchenker, Catherine Lacout, Jean‐Luc Villeval, Loïc Garçon, Jean‐Pierre Le Couedic, Annelise Bennaceur‐Griscelli, Nicole Casadevall, François Delhommeau and Hana Raslová and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Judith Staerk

32 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

2005 2.5k citations Chloé James, Valérie Ugo et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Staerk Belgium	22	3.1k	2.9k	2.0k	1.1k	894	34	5.0k
Mingjiang Xu United States	34	3.0k 1.0×	1.5k 0.5×	1.7k 0.8×	585 0.5×	368 0.4×	101	4.4k
Joanne C. Mountford United Kingdom	31	1.6k 0.5×	982 0.3×	1.2k 0.6×	482 0.4×	358 0.4×	69	3.2k
Loïc Garçon France	20	1.8k 0.6×	2.5k 0.9×	1.9k 1.0×	935 0.8×	567 0.6×	86	4.0k
Isabelle Plo France	30	2.3k 0.7×	1.4k 0.5×	1.4k 0.7×	396 0.4×	650 0.7×	99	3.4k
Elizabeth McDowell United States	6	1.7k 0.6×	1.4k 0.5×	1.4k 0.7×	444 0.4×	331 0.4×	9	2.8k
Claudia S. Huettner United States	24	1.5k 0.5×	689 0.2×	1.5k 0.7×	171 0.2×	714 0.8×	44	3.3k
Mats Ehinger Sweden	30	1.5k 0.5×	761 0.3×	796 0.4×	110 0.1×	847 0.9×	86	3.2k
Simona Colla United States	26	2.0k 0.6×	507 0.2×	2.2k 1.1×	117 0.1×	1.4k 1.5×	78	3.5k
Neill A. Giese United States	26	2.2k 0.7×	1.8k 0.6×	1.0k 0.5×	98 0.1×	650 0.7×	43	4.5k
Mikhail L. Gishizky United States	20	1.7k 0.5×	446 0.2×	698 0.3×	246 0.2×	717 0.8×	30	3.0k

Countries citing papers authored by Judith Staerk

Since Specialization

Citations

This map shows the geographic impact of Judith Staerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Staerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Staerk more than expected).

Fields of papers citing papers by Judith Staerk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Staerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Staerk. The network helps show where Judith Staerk may publish in the future.

Co-authorship network of co-authors of Judith Staerk

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Staerk. A scholar is included among the top collaborators of Judith Staerk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Staerk. Judith Staerk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papadopoulos, Nicolas, et al.. (2023). Modulation of human thrombopoietin receptor conformations uncouples JAK2 V617F-driven activation from cytokine-induced stimulation. Blood. 142(21). 1818–1830. 2 indexed citations

Defour, Jean‐Philippe, Emilie Leroy, Thomas Balligand, et al.. (2023). Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers. eLife. 12. 3 indexed citations

Çağlayan, Şafak, Artur Cieślar‐Pobuda, Vidar R. Jensen, et al.. (2020). Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation. iScience. 23(6). 101154–101154. 24 indexed citations

Luhr, Morten, Maria Lyngaas Torgersen, Paula Szalai, et al.. (2019). The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress. Journal of Biological Chemistry. 294(20). 8197–8217. 138 indexed citations

Tekpli, Xavier, Alfonso Urbanucci, Cathrine Broberg Vågbø, et al.. (2016). Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells. Epigenetics & Chromatin. 9(1). 21–21. 18 indexed citations

Karlsen, Tommy A., et al.. (2016). Generation of IL1β-resistant chondrocytes using CRISPR-CAS genome editing. Osteoarthritis and Cartilage. 24. S325–S325. 16 indexed citations

Hanna, Jacob H., Styliani Markoulaki, Maisam Mitalipova, et al.. (2015). Metastable Pluripotent States in NOD-Mouse-Derived ESCs. Cell stem cell. 16(5). 566–568.

Leroy, Emilie, Jean‐Philippe Defour, Takeshi Sato, et al.. (2015). His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor. Journal of Biological Chemistry. 291(6). 2974–2987. 23 indexed citations

Hanna, Jacob H., Styliani Markoulaki, Maisam Mitalipova, et al.. (2015). Metastable Pluripotent States in NOD-Mouse-Derived ESCs. Cell stem cell. 17(2). 245–246.

10.

Staerk, Judith & Stefan N. Constantinescu. (2012). The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective. PubMed. 1(3). 184–190. 52 indexed citations

11.

Staerk, Judith, Costas A. Lyssiotis, Michael J. Bollong, et al.. (2011). Pan‐Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells. Angewandte Chemie International Edition. 50(25). 5734–5736. 44 indexed citations

12.

Staerk, Judith, Jean‐Philippe Defour, C. Pecquet, et al.. (2011). Orientation‐specific signalling by thrombopoietin receptor dimers. The EMBO Journal. 30(21). 4398–4413. 64 indexed citations

13.

Hornakova, Tekla, Judith Staerk, Yohan Royer, et al.. (2009). Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers. Journal of Biological Chemistry. 284(11). 6773–6781. 54 indexed citations

14.

Hanna, Jacob H., Styliani Markoulaki, Maisam Mitalipova, et al.. (2009). Metastable Pluripotent States in NOD-Mouse-Derived ESCs. Cell stem cell. 4(6). 513–524. 253 indexed citations

15.

Wernig, Marius, Christopher J. Lengner, Jacob H. Hanna, et al.. (2008). A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nature Biotechnology. 26(8). 916–924. 330 indexed citations

16.

Dusa, Alexandra, Judith Staerk, Joanne Elliott, et al.. (2008). Substitution of Pseudokinase Domain Residue Val-617 by Large Non-polar Amino Acids Causes Activation of JAK2. Journal of Biological Chemistry. 283(19). 12941–12948. 45 indexed citations

17.

Lee, Youngkyun, Seok‐Won Hyung, Hee Jung Jung, et al.. (2007). The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-β–induced inhibitory signaling. Blood. 111(2). 885–893. 38 indexed citations

18.

Royer, Yohan, Judith Staerk, Marcel Costuleanu, Pierre J. Courtoy, & Stefan N. Constantinescu. (2005). Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability. Journal of Biological Chemistry. 280(29). 27251–27261. 124 indexed citations

19.

James, Chloé, Valérie Ugo, Jean‐Pierre Le Couedic, et al.. (2005). A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 434(7037). 1144–1148. 2540 indexed citations breakdown →

20.

Royer, Yohan, Judith Staerk, Katharina F. Kubatzky, et al.. (2003). Active and Inactive Orientations of the Transmembrane and Cytosolic Domains of the Erythropoietin Receptor Dimer. Molecular Cell. 12(5). 1239–1250. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact